|
|
|
Insider
Information: |
Tierney David S |
Relationship: |
CEO, Director |
City: |
South Plainfield |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
8,284,057 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,213,096 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
8,284,057 |
|
|
Total
Value |
$6,213,096 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
6
|
Stock
price went up :
|
2
|
4
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
Percentage
Gain/Loss : |
1.3%
|
163.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Catalyst Pharmaceutical Partners... |
CPRX |
Director |
2024-04-08 |
348,874 |
|
0 |
Premium* |
|
Seelos Therapeutics Inc |
SEEL |
Director |
2009-10-06 |
267,948 |
2007-02-01 |
0 |
Premium* |
|
Bioject Medical Technologies Inc |
BJCT |
Director |
2014-04-30 |
156,400 |
2007-12-14 |
0 |
Premium* |
|
Kempharm, Inc |
KMPH |
Director |
2023-03-09 |
10,835 |
2015-04-21 |
0 |
Premium* |
|
Timber Pharmaceuticals Inc |
TMBR |
CEO, Director |
2018-09-19 |
7,500,000 |
2018-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TMBR |
Timber Pharmaceuticals In... |
CEO |
|
2018-09-19 |
4 |
B |
$0.20 |
$20,250 |
D/D |
100,000 |
7,500,000 |
2.81 |
- |
|
BJCT |
Bioject Medical Technolog... |
Director |
|
2014-04-30 |
4 |
OE |
$0.75 |
$58,800 |
D/D |
78,400 |
156,400 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2008-08-12 |
4 |
A |
$1.47 |
$103,370 |
D/D |
70,320 |
213,752 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2017-11-09 |
4 |
OE |
$0.47 |
$23,500 |
D/D |
50,000 |
313,401 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2021-08-13 |
4 |
S |
$6.08 |
$303,895 |
D/D |
(50,000) |
306,874 |
0 |
% |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2021-08-13 |
4 |
OE |
$3.12 |
$156,000 |
D/D |
50,000 |
356,874 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2023-12-12 |
4 |
OE |
$1.13 |
$56,500 |
D/D |
50,000 |
383,541 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2023-12-12 |
4 |
S |
$13.33 |
$666,250 |
D/D |
(50,000) |
333,541 |
0 |
% |
|
BJCT |
Bioject Medical Technolog... |
Director |
|
2008-12-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
42,000 |
0 |
- |
|
BJCT |
Bioject Medical Technolog... |
Director |
|
2009-06-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
78,000 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2007-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
48,200 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2014-10-16 |
4 |
OE |
$0.90 |
$27,000 |
D/D |
30,000 |
243,401 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2015-10-27 |
4 |
OE |
$1.09 |
$32,700 |
D/D |
30,000 |
273,401 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2023-04-05 |
4 |
OE |
$0.79 |
$23,700 |
D/D |
30,000 |
343,541 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2023-04-05 |
4 |
S |
$16.83 |
$504,900 |
D/D |
(30,000) |
313,541 |
0 |
% |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2024-04-08 |
4 |
OE |
$4.01 |
$100,250 |
D/D |
25,000 |
373,874 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2024-04-08 |
4 |
S |
$15.68 |
$392,000 |
D/D |
(25,000) |
348,874 |
0 |
% |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2008-01-09 |
4 |
A |
$1.48 |
$36,000 |
D/D |
24,324 |
133,205 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
246,532 |
0 |
- |
|
SEEL |
Seelos Therapeutics Inc |
Director |
|
2007-09-12 |
4 |
A |
$1.60 |
$32,000 |
D/D |
20,000 |
98,654 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2012-05-29 |
4 |
B |
$0.58 |
$11,696 |
D/D |
20,000 |
205,401 |
2.39 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2022-05-20 |
4 |
S |
$0.00 |
$0 |
D/D |
(20,000) |
308,207 |
0 |
% |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2022-05-20 |
4 |
OE |
$2.53 |
$50,600 |
D/D |
20,000 |
328,207 |
0 |
- |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2022-08-22 |
4 |
S |
$14.16 |
$283,180 |
D/D |
(20,000) |
308,207 |
0 |
% |
|
CPRX |
Catalyst Pharmaceutical P... |
Director |
|
2022-08-22 |
4 |
OE |
$2.53 |
$50,600 |
D/D |
20,000 |
328,207 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|